New research suggests that exosomes could play an important role in brain circuits, cell signaling and cell communication.
Looking at your phone in the middle of the night won’t affect your body’s overall circadian rhythm, researchers suggest, as short-term and long-term exposure to light is processed via different pathways.
This week in industry we’re taking a look at the discontinuation of umibecestat and Acthar® Gel for Alzheimer’s and ALS, respectively, as well as the drug discovery shift from the amyloid approach in the Alzheimer’s field.
New studies presented at AAIC 2019 reveal that sex-specific differences could play a role in the risk, progression and resilience of Alzheimer’s disease.
Studies presented at AAIC 2019 have revealed the significant advances being made in the global search for blood-based biomarkers for dementia.
Observational studies reveal that use of sleep medications can increase an individual’s chances of developing dementia in sex-specific and race-specific ways.
Studies presented at AAIC 2019 provide potential treatment methods for the improvement of sleep quality in individuals with dementia.
New studies reported at AAIC 2019 are addressing the evolving and expanding role of technology in dementia care, prevention and alleviating burden.
New research into the LGBT community and risk of dementia have been reported at AAIC 2019, highlighting that the LGBT community may have a higher risk of cognitive decline.
Studies reported at AAIC 2019 have demonstrated the links between lifestyle factors and dementia; this information could provide new insight into the best ways to alleviate the likelihood of developing the disease.